drugset / Trial / NCT03362905

Lidocaine for Pain Control During Intrauterine Device Insertion

NCT03362905 ↗

Phase 4 Unknown 123 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

Despite being the most common method of contraception, the use of intrauterine devices (IUDs) is limited by the associated pain during insertion. Many pharmacologic interventions had been studied for their efficacy to reduce IUD insertion pain, of them, lidocaine was found to be superior over NSAIDs or other local anesthetics. This work aims at comparing the safety and efficacy of different lidocaine formulations to optimize selection in reduction of IUD associated pain.

Timeline

Start
2017-12-03
Primary completion
2018-12-05
Completion
2019-01-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 40 mg Topical
Subject Lidocaine Other / unclassified 80 mg Topical
Subject Lidocaine Other / unclassified 200 mg Topical
Subject Lidocaine Other / unclassified 2 g Topical

Indications

No indication recorded.